Status:
TERMINATED
Study on Systemic and Airway Cytokines and Oxidative Stress in Lung Cancer Patients Undergoing Surgery
Lead Sponsor:
The University of Hong Kong
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Lung cancer has remained as the top cancer killer in Hong Kong. Even for early resectable stage of lung cancer, only around 60-70% of patients can survive for 5 years after operation, mostly related t...
Detailed Description
Lung cancer is the major cause of cancer deaths among both genders in Hong Kong. In 2005, primary lung cancer accounted for 33% and 25% of all cancer deaths in men and women respectively. On average, ...
Eligibility Criteria
Inclusion
- Histologically or cytologically confirmed early-stage non-small cell lung cancer undergoing curative surgical lung resections.
- Life expectancy \> 12 weeks.
Exclusion
- Respiratory failure requiring use of supplemental oxygen therapy.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00956852
Start Date
September 1 2008
End Date
December 1 2015
Last Update
May 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong